New York Sleep Disorder Center is categorized under Doctors in Bronx, NY and active since 2012.
New York Sleep Disorder Center was established in 2012, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Doctors business, which does work in the B2C market, and is classified as a Doctors, under code number 6219996 by the NAICS.
If you are seeking more information, feel free to contact Mohammad Basit, Owner at the company’s single location by writing to 2951 Grand Concourse, Bronx, New York NY 10468 or by phoning (718) 220-4210. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | New York Sleep Disorder Center |
| Contact Person: | Mohammad Basit, Owner |
| Address: | 2951 Grand Concourse, Bronx, New York 10468 |
| Phone Number: | (718) 220-4210 |
| Website Address: | nysleepcenter.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2012 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6219996 |
| Share This Business: |
New York Sleep Disorder Center was started in 2012 to provide professional Doctors under the SIC code 8011 and NAICS code 6219996. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Mohammad Basit, Owner for inquiries that concern New York Sleep Disorder Center by calling the company number (718) 220-4210, as your correspondence is most welcome. Additionally, the physical location of the single location of New York Sleep Disorder Center can be found at the coordinates 40.87217,-73.887898 as well as the street address 2951 Grand Concourse in Bronx, New York 10468.
For its online presence, you may visit New York Sleep Disorder Center’s website at nysleepcenter.com and engage with its social media outlets through on Twitter and on Facebook.